Uterine Cancer

Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma
OBJECTIVE: To evaluate the usefulness of pre-operative serum CA-125 in the management of women diagnosed with uterine papillary serous carcinoma (UPSC).
55 Fruit St.
Boston, MA 02214
USA
MVP expression is related to IGF1-R in cervical carcinoma patients treated by radiochemotherapy
OBJECTIVE: To assess the expression of MVP in cervix carcinoma patients treated by radiochemotherapy, its relation to clinical and pathologic prognostic factors and its role in predicting clinical outcome.

Las Palmas de Gran Canaria, Spain
Spain
Patterns of care for women with cervical cancer in the United States
BACKGROUND: Recommendations for pretreatment evaluation and treatment of cervical cancer have significantly evolved over the last decade because of the results of multiple randomized studies comparing the addition of platin-based chemoradiation as well as the widespread dissemination and use of imaging modalities.

Bethesda, MD 20892-7436
USA
The vascular portion of the cardinal ligament: surgical significance during radical hysterectomy for
OBJECTIVE: The objective of the study was to analyze the histopathologic content of the vascular portion of the cardinal ligament in patients undergoing radical hysterectomy for cervical cancer.

Tampa, FL
USA
Factors predicting tumour regression in locally advanced cervical adenocarcinoma treated with balloo
We retrospectively assessed the factors that may impede tumour reduction of locally advanced cervical adenocarcinoma treated with balloon-occluded arterial infusion chemotherapy (BOAI) as initial therapy.
1-1-2 Nakao, Asahi-ku
Yokohama, Japan
Japan
Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional te
PURPOSE: To compare bone marrow-sparing intensity-modulated pelvic radiotherapy (BMS-IMRT) with conventional (four-field box and anteroposterior-posteroanterior [AP-PA]) techniques in the treatment of cervical cancer.

La Jolla, CA
USA
An in vitro multistep carcinogenesis model for human cervical cancer
Human papillomaviruses (HPV) are believed to be the primary causal agents for development of cervical cancer, and deregulated expression of two viral oncogenes E6 and E7 in basal cells, mostly by integration, is considered to be a critical event for disease progression.

Tokyo, Japan
Japan
Feasibility study of docetaxel and nedaplatin for recurrent squamous cell carcinoma of the uterine c
BACKGROUND: To determine a new taxane plus platinum treatment regimen for squamous cell carcinoma of the uterine cervix (CSCC), a phase I feasibility study of docetaxel (DTX) plus nedaplatin (CDGP) combination therapy was conducted.
377-2 Ohno-Higashi Osakasayama Osaka 589-8511

Japan
Human papillomavirus vaccination: the policy debate over the prevention of cervical cancer—a comme
The human papillomavirus (HPV) family causes a variety of benign, premalignant, and malignant lesions in men and women.

Miami, FL 33101
USA
Cyclooxygenase inhibitors block uterine tumorigenesis in HMGA1a transgenic mice and human xenografts
Uterine cancer is a common cause for cancer death in women and there is no effective therapy for metastatic disease.

Baltimore, MD 21205
USA